Abstract:Objective: To determine how dysfunctional astrocyte glutamate transporters contribute to microglial pruning of glutamatergic synapses and memory deficiency in Alzheimer’s disease (AD). Background: Astrocytes are the most abundant and heterogeneous type of glial cells in the brain, we tested the hypothesis that amyloid fibrils impair astrocyte glutamate transporters, thus leading to an abnormal accumulation of extrasynaptic glutamate, which in turn contributes to microglial pruning of glutamatergic synapses and memory deficiency in the rodent models of AD. Design/Methods: Aβ1–40 fibrils were microinjected bilaterally into hippocampal CA1 areas in rats. In another cohorts, DL-threo-beta-benzyloxyaspartate (DL-TBOA), a specific inhibitor of glutamate transporter 1 (GLT1), or ceftriaxone (used to enhance GLT1 function) were also microinjected into hippocampal CA1 areas. Immunostaining and immunoblotting were performed to detect the expression of GLT1 in astrocytes. Complement C1q production and microglial pruning of glutamatergic synapses were assessed by 3D immunofluorescence imaging. Morris water maze test was performed to evaluate the cognitive function. Results: A significant GLT1 reduction in the hippocampal astrocytes in rats injected with amyloid fibrils, indicating dysfunctional glutamate uptake. Microinjection of ceftriaxone significantly attenuated C1q expression and endocytosis of vGluT1 within microglia, and improved behavioral performance in the modeled rats. These results suggested that upregulation of GluT1 expression restored the synaptic microglial pruning and cognition impaired by amyloid fibrils. Meanwhile, in naive rats, microinjection of DL-TBOA substantially increased C1q expression, increased localization of vGluT1 within microglia, and impaired performance in the Morris water maze. This suggests that dysfunctional GluT1, which likely leads to extracellular accumulation of glutamate, contributes to C1q-mediated microglial pruning of synapses and cognitive deficits induced by amyloid fibrils. Conclusions: Reduction of astrocytic GLT1 contributes to C1q production and microglial pruning of glutamatergic synapses, hippocampal synaptic dysfunction and memory deficit in the AD model. Disclosure: Dr. Wu has nothing to disclose. Dr. Bie has nothing to disclose. Dr. Naguib has nothing to disclose.

Reduction of Astrocytic Glutamate Transporter Contributes to Amyloid-induced phagocytosis

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

Amyloid Fibril–Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses

Activation of Mglur1 Mediates C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer’s Rodent Models

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling

Glutaminase C Regulates Microglial Activation and Pro-inflammatory Exosome Release: Relevance to the Pathogenesis of Alzheimer’s Disease

The Downregulation of ITGAX Exacerbates Amyloid-β Plaque Deposition in Alzheimer's Disease by Increasing Polarization of M1 Microglia

The Difference in Gliosis Induced by Β-Amyloid and Tau Treatments in Astrocyte Cultures Derived from Senescence Accelerated and Normal Mouse Strains

Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.

Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease

Astrocyte-specific knockout of YKL-40/Chi3l1 reduces Aβ burden and restores memory functions in 5xFAD mice

Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance

Alzheimer’s Disease Enhanced Tonic Inhibition is Correlated With Upregulated Astrocyte GABA Transporter-3/4 in a Knock-In APP Mouse Model

Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency

Cognitive impairment in Alzheimer's disease FAD 4T mouse model: Synaptic loss facilitated by activated microglia via C1qA

Astrocyte-derived MFG-E8 facilitates microglial synapse elimination in Alzheimer's disease mouse models

C5aR1 signaling promotes region‐ and age‐dependent synaptic pruning in models of Alzheimer's disease

Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss

Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer’s Disease: A Targeted Transcriptome Analysis

Blockade of Type 2A Protein Phosphatase Signaling Attenuates Complement C1q-Mediated Microglial Phagocytosis of Glutamatergic Synapses Induced by Amyloid Fibrils

GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration